Over the past few years of his PhD research, Harim Won has been laying the groundwork to develop a new type of antibiotic to treat tuberculosis (TB), addressing the long-standing problems of lengthy treatments and antibiotic resistance. Won is using a new approach to turn a normal protein system in the bacterial cell against itself.
Won, who works in the lab of Eric Rubin, adjunct professor of immunology and infectious diseases at Harvard T.H. Chan School of Public Health, is completing a degree in biological sciences in public health.
